Arrowhead Pharmaceuticals, Inc. company logo
Arrowhead Pharmaceuticals, Inc. logo

ARWR Cash From Financing

Annual CFF

$74.01M$796.51M-91.50%

Summary

Current Value
As of today, ARWR annual cash from financing is $74.01M, down -91.50% on
Historical Performance
ARWR annual cash from financing is up +13.53% over the past 3 years, and down -71.31% over the past 5 years
All-Time High Comparison
ARWR annual cash from financing is currently -91.50% below its historical high of $870.52M set on
3-Year Low Comparison
ARWR annual cash from financing is +13.53% above its 3-year low of $65.19M reached on an earlier date
Sector Comparison
ARWR annual cash from financing is higher than 78.50% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

ARWR Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$74.01M-91.5%+13.5%-71.3%+514.7%
Quarterly Cash From Financing$3.67M-99.1%+329.1%+265.3%+1049.8%
TTM Cash From Financing$74.01M-91.5%+13.5%-71.3%+514.7%
Price$65.55+263.1%+78.0%-20.9%+608.6%
Annual Cash From Operations$179.55M+138.8%+231.9%+288.2%+2432.9%
Annual Cash From Investing-$129.29M+69.2%-2286.8%+46.3%-10000.0%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$733.68M-13.9%+799.4%+3370.9%+10000.0%
Shares Outstanding139.41M+11.0%+30.8%+35.1%

Cash From Financing Highs

ARWR Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$870.52M-91.5%
5Y$870.52M-91.5%
All$870.52M-91.5%

Cash From Financing Lows

ARWR Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$65.19MN/A+13.5%
5Y$11.31M+554.6%
All-$4,400.00>+9999.0%

Cash From Financing History

YearValueChange
$74.01M-91.5%
$870.52M+244.0%
$253.05M+288.2%
$65.19M+476.6%
$11.31M-95.6%
$257.95M+288.6%
$66.38M+10.7%
$59.95M+397.3%
$12.06M-78.1%
$55.13M>+9,900.0%
$290.50K-99.8%
$185.29M+318.4%
$44.29M+311.3%
$10.77M+73.0%
$6.23M-48.3%
YearValueChange
$12.04M+86.2%
$6.47M-59.9%
$16.13M+3.5%
$15.59M-25.4%
$20.89M+0.7%
$20.74M+110.1%
$9.87M+551.6%
$1.52M+1,105.3%
$125.70K+56.9%
$80.10K-3.1%
$82.70K+141.1%
$34.30K-25.4%
$46.00K+1,145.5%
-$4,400.00-

FAQ

  • What is the current annual cash from financing of ARWR?

    As of today, ARWR annual cash from financing is $74.01M

  • What is 1-year change in ARWR annual cash from financing?

    ARWR annual cash from financing is down -91.50% year-over-year

  • What is 3-year change in ARWR annual cash from financing?

    ARWR annual cash from financing is up +13.53% over the past 3 years

  • How far is ARWR annual cash from financing from its all-time high?

    ARWR annual cash from financing is currently -91.50% below its historical high of $870.52M set on September 30, 2024

  • How does ARWR annual cash from financing rank versus sector peers?

    ARWR annual cash from financing is higher than 78.50% of companies in Healthcare sector

  • When is ARWR next annual earnings release?

    As of today, the next annual earnings release for ARWR has not been scheduled

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. ARWR Official Website arrowheadpharma.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
  3. ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
  4. ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr